Business model

For our customers and partners we custom engineer ”InGell” injectable hydrogel systems towards the optimal release profile of the active pharmaceutical ingredient in play.

Our business model is a combination of dedicated development agreements, licensing agreements and supply agreements.

Collaborations are always custom-made but generally follow the path of:

1. Feasilibility studies;

2. Basic agreement on licensing conditions;

3. Full development program;

4. Full agreement on licensing conditions;

5. Supply chain securement.